DiscoverThe Bioinformatics CRO PodcastYuri Deigin - Partial Reprogramming Drug Development for Aging
Yuri Deigin - Partial Reprogramming Drug Development for Aging

Yuri Deigin - Partial Reprogramming Drug Development for Aging

Update: 2023-03-03
Share

Description

Yuri Deigin, co-founder of YouthBio Therapeutics, discusses developing rejuvenation gene therapies based on partial reprogramming and his role reinvigorating investigations into the origins of SARS-CoV-2.

The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of biotechnology companies, with a focus on genomics.

https://www.bioinformaticscro.com/

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Yuri Deigin - Partial Reprogramming Drug Development for Aging

Yuri Deigin - Partial Reprogramming Drug Development for Aging